Diagnosis and treatment

Residents line up to get tested at a coronavirus testing center set up outside a sports facility in Beijing, Tuesday, June 16, 2020. China reported several dozen more coronavirus infections Tuesday as it increased testing and lockdown measures in parts of the capital to control what appeared to be its largest outbreak in more than two months. (AP Photo/Ng Han Guan)
June 16, 2020 - 12:59 pm
ATLANTA (AP) — As nations grapple with new outbreaks and spiking death tolls from the coronavirus, a commonly available drug appeared Tuesday to offer hope that the most seriously ill could have a better chance of survival. The pandemic has forced countries to impose lockdowns and tough...
Read More
FILE - In this Aug. 6, 2019, file photo file photo, Marijuana plants growing under special grow lights, at GB Sciences Louisiana, in Baton Rouge, La. State lawmakers are poised to greatly expand Louisiana's medical marijuana to make more people eligible for the treatment, under a bill that continued Wednesday, May 20, 2020, to speed toward final passage. (AP Photo/Gerald Herbert, File)
June 16, 2020 - 11:18 am
BATON ROUGE, La. (AP) — More Louisiana residents will have access to medical marijuana under a significant expansion of the state's therapeutic cannabis program that was signed into law by Gov. John Bel Edwards. The changes in the law, which take effect in August, allow doctors to recommend medical...
Read More
FILE - In this Sunday, June 14, 2020 file photo, medical workers attend to a COVID-19 patient in an intensive care unit at a hospital in Sanaa, Yemen. Researchers in England say they have the first evidence that a drug can improve survival from COVID-19. The drug is a cheap, widely available steroid called dexamethasone. Results released Tuesday, June 16 show it reduced deaths by up to one third in severely ill hospitalized patients. (AP Photo/Hani Mohammed, File)
Associated Press
June 16, 2020 - 6:37 am
Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients. Results were announced Tuesday and researchers said they would publish...
Read More
FILE - In this Aug. 2, 2018, file photo, the U.S. Food and Drug Administration (FDA) building is visible behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday, June 15, 2020, the game built by Boston-based Akili Interactive Labs can improve attention function. (AP Photo/Jacquelyn Martin, File)
June 15, 2020 - 4:17 pm
BOSTON (AP) — The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday the game built by Boston-based Akili Interactive Labs can improve attention function. The game, called EndeavorRx,...
Read More
FILE - In this April 9, 2020 file photo, a chemist displays hydroxychloroquine tablets in New Delhi, India. U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19. The Food and Drug Administration said Monday, June 15 that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. (AP Photo/Manish Swarup, File)
June 15, 2020 - 2:27 pm
WASHINGTON (AP) — U.S. regulators on Monday revoked emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19 amid growing evidence they don’t work and could cause serious side effects. The Food and Drug Administration said the drugs hydroxychloroquine and...
Read More
FILE - In this May 2, 2017 file photo, Morocco's King Mohammed VI, left, smiles as he arrives at the Elysee Palace to meet France's President Francois Hollande in Paris. King Mohammed VI of Morocco underwent successful heart surgery on Sunday in Rabat for a heart rhythm disorder, according to the state news agency. The king, 56, was treated for a heart rhythm disorder known as "atrial flutter," in which the heart's upper chambers beat too quickly. (AP Photo/Michel Euler, File)
June 15, 2020 - 3:05 am
RABAT, Morocco (AP) — King Mohammed VI of Morocco has undergone successful surgery in Rabat for a heart rhythm disorder, state news agency MAP reported Monday. The king, 56, was treated for a disorder known as atrial flutter, a non-life-threatening condition in which the heart beats less...
Read More
This X-ray image provided by Northwestern Medicine in June 2020 shows the chest of a COVID-19 patient before she received a new set of lungs because of severe lung damage from the coronavirus, at Northwestern Memorial Hospital in Chicago. (Northwestern Medicine via AP)
June 11, 2020 - 4:02 am
Surgeons in Chicago have given a new set of lungs to a young woman with severe lung damage from the coronavirus. Only a few other COVID-19 survivors, in China and Europe, have received lung transplants. The patient, who is her 20s, was on a ventilator and heart-lung machine for almost two months...
Read More
People wear face masks to protect against the spread of the new coronavirus as they walk past a billboard encouraging people to protect pangolins in Beijing, Wednesday, April 15, 2020. China reported several dozen new coronavirus cases on Wednesday, mostly from overseas. (AP Photo/Mark Schiefelbein)
June 05, 2020 - 8:10 pm
BEIJING — China is ordering its highest level of protection for the armadillo-like pangolin as part of its crackdown on the wildlife trade following the global coronavirus pandemic. While the virus is believed to have originated in the central Chinese city of Wuhan, most scientists say it was most...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine pills in Las Vegas. On Friday, June 5, 2020, leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. (AP Photo/John Locher)
June 05, 2020 - 9:34 am
Leaders of a large study in the United Kingdom that is rigorously testing the malaria drug hydroxychloroquine and other medicines for hospitalized COVID-19 patients say they will stop putting people on the drug because it’s clear it isn’t helping. Results released Friday from 1,542 patients showed...
Read More
FILE - This April 7, 2020 file photo shows a bottle of hydroxychloroquine tablets in Texas City, Texas. Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. A retraction in the journal Lancet on Thursday, June 4, 2020 involved a May 22 report on hydroxychloroquine and chloroquine, drugs long used for preventing or treating malaria but whose safety and effectiveness for COVID-19 are unknown. (AP Photo/David J. Phillip, File)
June 04, 2020 - 1:53 pm
Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report, saying independent reviewers were not able to verify information that’s been widely questioned by other scientists. Thursday’s retraction in the journal Lancet...
Read More

Pages